U.S. FDA says it met with states interested in importing cheaper drugs from Canada

The FDA met this month with several U.S. states and Indigenous communities to help them import lower-cost Canadian pharmaceuticals under a program that has drawn disapproval from Ottawa. The engagement could facilitate state-level efforts to reduce drug costs domestically but raises diplomatic friction with Canada and potential legal or supply-chain challenges cross-border.

Analysis

The FDA met this month with several U.S. states and Indigenous communities to help them import lower-cost Canadian pharmaceuticals under a program that has drawn disapproval from Ottawa. The engagement could facilitate state-level efforts to reduce drug costs domestically but raises diplomatic friction with Canada and potential legal or supply-chain challenges cross-border.